Biocompatible and pH-sensitive poly (N-isopropylacrylamide-co-methacrylic acide-co-vinylpyrrolidone) [P(NIPAAm-MAA-VP)] nanofibers were prepared as a delivery vehicle for sustained release of doxorubicin hydrochloride (DOX) as an anticancer drug. The structure and morphology of nanofibers were investigated by SEM, FTIR, and XRD. P(NIPAAm-MAA-VP)–DOX complex was formed at pH 7 because of ionic interactions between DOX and polymers. P (NIPAAm-MAA-VP) nanofibers tailored to desire diameters with bead free morphology by optimizing the electrospinning parameters DOX release from P (NIPAAm-MAA-VP)/DOX complex was investigated as a biological on–off switch for the design of an intelligent drug delivery system triggered by external pH changes.
No takes yet. Share an insight, caveat, or question.
Salehi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: